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1. Introduction 
Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder, which represents 
the main cause of visual impairment and blindness in preterm infants (Drack,1998).ROP 
develops in 84% of premature survivors born at <28 weeks of gestation (Palmer et 
al,1991). Fortunately, it resolves in most cases (80%) without visual loss from retinal 
detachment or scars (Palmer et al, 1991; Cryotherapy for retinopathy of prematurity 
cooperative group, 1994). In this study, the total ROP incidence was 0.17% overall and 
15.58% for premature infants with length of stay of more than 28 days (Lad et al, 2009). 
The increased survival of very small premature infants has led to the resurgence of this 
potentially blinding disease (Kinsey et al 1977; Shohat et al 1983)The pathogenesis of ROP 
isn’t fully known. The altered regulation of vascular endothelial growth factor from 
reported episodes of hyperoxia and hypoxia is an important factor in the pathogenesis of 
ROP (Chow et al 2003). Apparently, any severe physiologic stress may damage the 
developing capillaries in immature retina and in response to ischemia, new vessel 
(neovascular) growth resumes (Phelps, 1992).ROP appears to be a multifactorial disease. 
Given the multifactorial nature of ROP and close relation of the most risk factors to 
prematurity, it is difficult to define the specific role of any individual factor in the 
pathogenesis of ROP (Hesse et al 1997). 
Blood transfusion has been identified as a risk factor for ROP in several studies (Shohat et 
al,1983;Cats& Tan KEW ,1985 ;Clark et al ,1981; Cooke et al ,1993;Sacks et al ,1981;Yu & 
Hookham& Nave ,1982);Some investigator, however, could not confirm this associating 
(Bossi et al, 1984; Brown,1987 ;Lechner& Kalina& Hodson,1977).The damaging effects of 
blood transfusion on the retina are mediated via an increase in free iron that may catalyze 
fenton reactions, which produce free hydroxyl radicals capable of damaging the retina 
(Sullivan, 1988).Preterm infants are particularly susceptible to iron overload because of 
frequent transfusions and low levels of iron – binding proteins (Sullivan, 1988).In an effort 
to limit the risks associated with RBC transfusion, many neonatal units have adopted more 
restrictive guidelines for transfusing preterm infants (Widness et al ,1996 ;Alugappan& 
Shattuck& Malloy ,1998;Maies et al 2000 ;Franz & Pohlandt,2001),but the safety or potential 
benefits of restricting transfusions have not been adequately tested.  
www.intechopen.com
 
Blood Transfusion in Clinical Practice 
 
130 
2. Retinopathy of prematurity 
2.1 History 
ROP was first described by Terry in 1942 as retrolental fibroplasias (Terry, 1942) and a few 
years later was recognized as one of the leading causes of infant blindness 
(Zacharias,1952).The indiscriminate use of oxygen from the 1940s to the mid-1950s was 
associated with a very high incidence of ROP. After the widespread adoption of the New York 
city health departments recommendation to restrict supplemental O2 concentrations to 40% 
,the incidence of ROP decreased dramatically (James & Lamman,1976). During the 1960s it 
became obvious that although ROP incidences had decreased ,the oxygen restriction appeared 
to be associated with a significant increase of infant morbidity and mortality from hyaline 
membrane disease (Avery& Oppenheimer, 1960) and brain injury (McDonald, 1963). Oxygen 
supplementation was therefore liberalized in the late 1960s, and incidence of ROP began to  
rise again. 
In the late 1960s, the incidence of ROP began to rise again. This increase continued during 
the 1970s and 1980s, likely as a result of the improved survival rate of very low birth weight 
infants associated with advances in neonatal medicine (Valentine et al, 1991).However, with 
improved technology and new techniques in neonatal nursing care, very low birth weight 
infants are now surviving with decreasing morbidity, and it is possible that the recent 
advances, that produced this change have also had an effect on ROP incidence (Bullord  
et al, 1998). 
2.2 Incidence and risk factors 
Kinsey et al found the incidence of ROP to be 38% in infants weighing 1200 g or less (Kinsey 
et al 1977.The CRYO-ROP trials reported an incidence of 65.8%,Infants weighing less than 
1251 g and 81.6% in those less than 1000 g (Palmer et al, 1991). Many other studies reported 
ROP incidence ranging from 10% to 66% in infants with low birth weights in the United 
States and worldwide (Shohat et al 1983;Cats& Tan KEW ,1985; Bullord et al,1998;Fledelius& 
Dahl ,2000;Akkoyun et al,2006;Rowlands et al 2001;Hussain&Clive& Bhandori,1999;Wright 
et al,1998;Custick et al 2006;Yang et al 2006). 
Chiang and associates have reported that the incidences of ROP were 20.3%, 27.3% and 
33.2% in infants with a length of stay of more than 28 days with birth weight of less than 
1500 g, 1200 g and 1000 g respectively (Chiang et al. 2004). 
More recently Lad et al. in a large retrospective study based on the national Inpatient 
sample from 1997 through 2005 reported ROP incidence of 15.58% for premature infants 
with length of stay of more than 28 days (Lad et al, 2009). 
Several risk factors have been associated with ROP .The major risk factors are prematurity 
(low birth weight, low gestational age at delivery).An inverse relationship was found 
between birth weight and the incidence and severity of retinopathy of prematurity (Lad et 
al, 2009; Kinsey et al 1977; Shohat et al. 1983; Bossi et al, 1984; Gunn et al,1980;Hammer et 
al,1986;Patz,1969).This finding emphasize, that the degree of immaturity of the eye is the 
main predictive factor for the devolvement of ROP. 
Immature and underdeveloped retinal blood vessels in premature infants may be more 
vulnerable to postnatal environmental influences such as hyperoxic or hypoxic tissue injury, 
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hypercarbia, and metabolic acidosis (Quinn, 1998). Moreover, these adverse conditions have 
a better opportunity to affect retinal vascular development if more development is left to 
occur under their influence. For many years it was thought that oxygen therapy increased 
the risk of ROP in preterm infants, however (Reynolds et al, 1998), ROP can occur even with 
careful control of oxygen therapy (Akkoyun et al, 2006). In fact, the role of oxygen has been 
overemphasized in the past and excessive oxygen administration has not been identified as 
an independent risk factor(Mccolm& Fleck ,2001).A reasonable working hypothesis is that 
the developing retina is highly sensitive to any disturbance in its oxygen supply either 
hyperoxemic or hypoxemic (Lucey & Dangman,1984). 
Other proposed risk factors that are under study and may not be causally linked to ROP 
include: metabolic acidosis (Bossi et al, 1984), metabolic alkalosis (Shohat et al 1983), 
hypercarbia (Bauer & Windmayer, 1981), hypocarbia (Brown,1987), transfusions 
(Brown,1987; Clark et al ,1981), light (Glass et al ,1985), intraventricular hemorrhages 
(Brown,1987), white race( Saunders et al ,1997),chronic lung disease (Biglan et al ,1984), 
seizures(Biglan et al ,1984),sepsis(Gunn et al,1980),xanthine administration (Hammer et 
al,1986), magnesium and copper deficiency (Caddell,1995), Vitamin E deficiency (Owens & 
Owens ,1949 ),selenium deficiency (Papp & Nemeth& Pelle ,1993), and multiple gestations 
(Bossi et al, 1984). Any change that affects the incidence or nature of one or more of these 
risk factors might also affect the incidence and severity of ROP. 
2.3 Pathogenesis 
ROP is a condition confined to the immature retinal vascular system. The likelihood of 
developing retinopathy is related to the degree of vascular development so that once the 
retina is fully vascularized the risk of developing ROP has passed. Normally, retinal 
vascular development progresses from the 16th week of gestation to the 40th week in a 
central to peripheral wave at a rate of about 0.1 mm/day (Payne& Patz, 1979). 
ROP alters this normal developmental progression, which instead follows a two –staged 
pathophysiologic course: an initial phase of vasoconstriction and arrested vessel growth, 
followed by a second phase of abnormal vessel proliferation. The onset of ROP generally 
requires two conditions. The first is incomplete retinal vascular development.ROP incidence 
and severity is directly proportional to the degree of prematurity that is, ROP outcome 
correlates with the size of the area of retinal avascularity at onset (Kinsey et al 1977, Schaffer 
et al, 1993, Kalina & Kari, 1982). The second condition involves exposure of the developing 
retina to an abnormal environmental influence and several have been suggested (Quinn, 
1998).Most prominent among these is retinal hyperoxia resulting from postnatal 
hyperoxemia in infants receiving supplemental oxygen to compensate for inadequate 
pulmonary function. This condition, alone or in combination with other as yet unidentified 
results, leads to cessation of retinal vessel development. The retinal vasculature then enters 
a quiescent phase for days or weeks, while the formation of a ridge-like structure develops, 
separating the central vascularized region of the retina from the peripheral avascular region. 
This structure, which is pathognomonic of ROP, historically consists of mesenchymal and 
endothelial cells. Concomitant development of retinal neurons with advancing postnatal age 
results in increasing oxygen requirements, which cannot be met by attenuated vessel 
compliment in retinal hypoxia (Weiter& Zucherman& Schepens 1982 ).As a result of 
hypoxia another as yet undefined stimulus, angiogenic growth factor induction occurs, 
www.intechopen.com
 
Blood Transfusion in Clinical Practice 
 
132 
followed by rapid growth of new vessels within the ridge .The new vessels can regress by 
involution and remodeling into a nearly normal vascular pattern or the growth can progress 
to extraretinal neovascularization (Nelson,1790). These extraretinal vessels are weak and 
prone to leakage. The result is vitreous hemorrhage, scarring and contraction, leading to 
retinal folds or detachments and vision (loss Foos, 1985). 
ROP is called stage 1 when the growing vessels end abruptly at a noticeable line separating 
the vascular and avascular retina takes on height and width ,it becomes a ridge and casts a 
little shadow; the ridge is stage 2 ROP .When the bunched up vessels in a stage 2 eye erupt 
into the vitreous ,The ROP becomes stage 3 and can be of variable severity .The greater the 
amount of extraretinal neovascularization vertically, and the greater the extent of the 
disease’s spread around the retina, the stage 3 will be more sever. If the ROP progresses 
further, exudative and tractional retinal detachments occur and may be partial (stage 4) or 
complete (stage 5) (Phelps, 1992). 
In the premature infants, the developing capillaries without a basement membrane or 
supporting predicts completely ablate during a prolonged period of absent retinal flow .it 
remains in dispute whether the vascular ablation in the premature infants is due to direct 
oxidative injury of the growing endothelium (Chan- Ling& Gock & Stone, 1995 ) Or is 
nearly the consequence of prolonged vasoconstriction due to a disturbed auto regulatory 
mechanism of the retinal vessels (Ashton & Cook,1954).The level of antioxidative in the 
immature retina is relatively low and therefore oxygen radicals which accumulate in the 
preterm baby’s retina may play an important role in the pathogenesis of ROP (Hesse  
et al, 1997). 
2.4 Terminology of ROP  
The severity of ROP is described by four parameters: stage, location, extent and plus disease 
(table 1). 
2.5 Screening for ROP  
Since 1988, following the demonstration by the CRYO-ROP trial, sever ROP can be 
successfully treated so the ophthalmologists have had a duty to screen for this condition. 
The focus of screening is to identify ROP that requires treatment, at the appropriate point 
in the disease progression. The indication for treatment which has been reported in the 
CRYO-ROP study is threshold ROP. The term threshold denotes the ROP stage at which 
spontaneous and complete resolution is unlikely and the risk of blindness is predicted to 
be close to 50% (Cryotherapy for retinopathy of Prematurity Cooperative Group, 
1988).The CRYO-ROP study divided all the diseases of the stage 3 into two categories: 
pre-threshold (or moderate ROP) and threshold (or severe ROP).Any disease of the stage 
3 less than threshold was considered pre-threshold. Threshold ROP was defined as stage 3 
ROP in zones one and two, in the presence of plus disease. Further studies such as that 
published recently by the Early Treatment for Retinopathy of Prematurity Cooperative 
Group (ETROP) recommends treating eyes before threshold because the outcomes of 
some eyes treated once they have develop threshold disease has been poor (ET-
ROP,1997). 
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Parameter Description 
Stage  1  
  2 
 
 
 
  3 
 
 
 
 
 
 
 
  4 
 
 
  5 
Demarcation line at the advancing edge of the retinal blood vessels 
Ridge 
Stage 1 and 2 are referred to as mild ROP as they often undergo spontaneous 
resolution and do not result in visually disabling ophthalmic sequelae  
Ridge with Extraretinal Fibrovascular proliferation .This is the first stage of 
ROP that presents a significant risk of poor structural or visual outcome and 
thus represents serious disease. 
Shunt lesions are well developed at the demarcation line and are often 
associated with “plus” (posterior retinal congestion). 
Further progression is characterized by development of secondary vitreous 
haze which heralds the onset of vitreoretinopathy leading to more sight 
threatening sequelae  
Retinal detachment and partial retinal detachment 
a) the macula is attached 
b) the macula is detached 
Total Funnel Retinal detachment  
Stage IV and V result in some permanent visual impairment despite surgical 
intervention 
Location  
Zone 1-3 
This predictable pattern of retinal vascularisation was formally recognized 
by the international classification of retinopathy (ICROP) in 1984 and 1987, 
which divided the retina into progressive concentric zones. The location of 
ROP is described in terms of these three arbitrarily defined ICROP zones 
which are centered around the optic disk 
Extent 1-12 This is described by clock hours by 30 degree sectors. 
Plus disease Plus disease is characterized by active progression and at a more advanced 
stage the iris becomes congested resulting in poor pupil dilatation. The 
presence of the disease is an urgent indication for treatment 
Table 1. Terminology of retinopathy of prematurity (ROP) 
3. Blood transfusion in preterm infants 
Preterm infants, especially those with very low birth weight (VLBW) prematurity, often 
need multiple blood transfusions during hospitalization. Over 50-80% of VLBW preterm 
infants receive at least one blood transfusion during their neonatal intensive care unit 
(NICU) stay (Strauss, 1997). In addition to phlebotomy losses causing low hematocrit, most 
VLBW infants develop the anemia of prematurity (AOP) a hypopro liferative anemia 
marked by inadequate production of erythropoietin (EPO). Treatment of AOP include red 
blood cell transfusions which are given to preterm infants based on indications and 
guidelines (hematocrit/ hemoglobin levels, ventilation and oxygen) that are relatively non- 
specific (Bishara,2008).  
Transfusions to VLBW premature infants could increase weight gain, improve oxygenation 
and decrease lactic acidosis (Ohls, 2000). The complications and potential risk of blood 
transfusions include blood – transmitted infection, metabolic and cardiovascular 
complications, graft versus host disease, iron overload and increased oxidative stress, which 
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are thought to be related to complications in premature infants such as chronic lung disease 
(CLD) and retinopathy of prematurity (ROP) (Cooke et al ,1997;Saugstad ,2003;Englert  et al 
,2001;Wheatley et al ,2002)considering the available evidence, many neonatal units have 
adopted more restrictive transfusion guidelines to reduce the frequency of transfusions and 
donor exposure (Windes et al, 1996; Alagappan& Shattuck& Malloy,1998; Maier et al, 
2000;Franz & Pohlandt ,2001)But, these changes in practice have not been accompanied by 
systematic examination of the safety or potential benefits of restricting transfusions. 
Limiting RBC transfusion in preterm infants may reduce the potential risk of transfusion, 
but the resulting low hemoglobin levels may result in the morbidities associated with 
chronic anemic hypoxemia as recommended by some studies that advocate more than 
liberal transfusion guidelines to prevent apnea (Ross et al, 1989), to foster weight gain 
(Meyer & sive & Jacobs, 1993). More recent trials have been performed to determine the 
safety and efficacy of more restrictive transfusion guidelines.  
Bifano was the first to evaluate neonatal transfusion guideline in prospective fashion [76]. 
This study compared the clinical outcomes of two groups of Extremely Low Birth Weight 
(EBLW) infants who were randomly assigned to restrictive or liberal transfusion criteria, 
based on hemoglobin thresholds for transfusion. There were no differences between groups 
in growth, morbidities, or mortality during hospitalization. At 12 months follow up, there 
were no differences in overall neurodevelopmental impairment. This study suggested that a 
restrictive transfusion strategy was not associated with adverse outcomes.  
Bell et al. conducted a randomized trial of liberal versus restrictive guidelines for bronze 
baby syndrome (BBS) transfusion in preterm infants and showed that restrictive 
transfusions may be harmful to preterm infants in the restrictive group which had a greater 
incidence of intraparenchymal brain hemorrhage or periventricular leukomalacia and more 
frequent episodes of apnea (Bell et al, 2005). 
Bednorek et al. in a prospective study examined the relationships of high and low transfusion 
practice styles on neonatal outcomes (Bednorek et al ,1998).Multivariate analyses showed that 
infants cared for in the lower transfer NICU did not have an increased risk for several adverse 
outcomes including IVH, NEC, BPD, Lesser weight gain, and longer hospitalizations. 
Kirpalani et al, performed a study to determine whether extremely low birth weight infants 
transfused at lower hemoglobin thresholds versus higher thresholds have different rates of 
survival or morbidity at discharge (Kirpalani et al, 2006).These investigators concluded that, in 
ELBW infants, maintaining a higher hemoglobin level result in more infants receiving 
transfusions but confer little evidence of benefit. This study provided evidence that transfusion 
thresholds in ELBW infants can be moved downward at least 10g/L, without incurring a 
clinically important increase in the risk of death or major neonatal morbidity.  
However, most of the neonatal studies published up to the present measured what infants 
received, regardless of actual need for red cells. Transfusion guidelines and practices would 
benefit from studies that identify a useful transfusion marker, preferably one that requires 
minimal to no blood (Ohls, 2008). 
4. The effect of blood transfusion on ROP 
The role of blood transfusions as a risk factor for ROP was first suggested by Shohat et al 
(Shohat et al 1983), and other authors subsequently confirmed this association(Shohat et al 
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1983; Cats& Tan KEW ,1985; Clark et al ,1981; Cooke et al ,1993; Sacks et al,(1981); Ebrahim 
Mikaniki et al,2010; Yu & Hookham& Nave ,1982), some investigators, however, could not 
confirm it(Bossi et al, 1984; Brown,1987;Cooke et al; Lechner et al, 1977). multivariate 
regression analysis found that only gestational age and frequency of blood transfusions are 
independently associated with the risk of occurrence of ROP (Cooke et al ,1993).They 
reported a 9% increase in the risk of ROP with each transfusion given (95% CI 1.0-1.18). But 
data on iron metabolism were not analyzed and no information was given about the actual 
volume of transfused blood. Hesse et al demonstrated by the same statistical method, that 
blood transfusions are an independent risk factor for ROP. In this study, the relative risk of 
developing ROP was 6.4 (95% CI 1.2-33.4) for infants who received 16-45 ml/kg, and 12.3 
(1.6-92.5) for those who had received more than 45 ml/kg of blood (reference, 0-15 ml/kg) 
(Hesse et al 1997).In contrast, there was no independent relationship between ROP and any 
of the parameters on iron metabolism analysis. Inder et al after multivariate regression 
analysis, showed that an elevation of serum iron and transferring saturation at 7 days of age 
is associated with an increased risk of ROP: they could not demonstrate an independent role 
of blood transfusions as a risk factor for ROP, but demonstrated that the iron status and the 
amount of transfused blood are highly correlated factors (Inder et al, 1997). Boosi et al, in 
another study, could not confirm an independent role of blood transfusion on development 
of ROP (Bossi et al, 1984). 
Brooks et al, through a randomized, controlled trial, found that there was no association 
between hemoglobin or hematocrit ratios and ROP incidence or severity and transfusion 
limitation policy do not import a significant different risk for ROP (Brooks et al 1999)  
.However in this study, the risk of ROP was related to the number and not the volume of 
blood transfusion, and the incidence of ROP in the studied population was so high (76%) 
that it seems to be difficult to decrease the occurrence of ROP only by limiting the blood 
transfusions. More recently,Dani et al. showed that gestational age, blood transfusion 
volume and iron load by transfusions are associated with the risk of occurrence of ROP in 
infants with a birth weight of less than 1250 g. in this study, logistic regression analysis 
demonstrated that transfusion volume during the first week (OR 1.16; 95% CI 1.03-1.3) 
and during the first 2 months of life (OR 2.93; 95% CI 1.52-5.62), and iron intake during 
the first week of life (OR 1.15; CI 1.01-1.32) and during the first 2 months of life (OR 2.93; 
95% CI 1.52-5.62) were associated with the development of ROP[87]. Two mechanisms by 
which blood transfusion could contribute to the development of ROP are discussed. First, 
Transfusions increase oxygen carrying capacity and a decrease in oxygen affinity caused 
by an increase in the proportion of adult hemoglobin. Second, transfusion increase iron 
load.  
Sullivan Pointed out that the transfusion of 10 ml of packed red blood cells will increase the 
premature infant's total body iron by 20%, and that packed red blood cells contain 450 times 
as much hemoglobin iron as the plasma total iron- binding capacity (Sullivan,JL,1988) .This, 
in conjunction with the reduced iron- binding capacity of preterm infants (due to their low 
transferring and ceruloplasmine levels) and postnatal depression of erythrocyte production, 
makes preterm infants who are repeatedly transfused extremely susceptible to an 
accumulation of increased amounts of free iron. Free iron could catalyze fenton reactions 
which produce highly reactive oxygen-derived free radicals and are assumed to play an 
important role in the pathogenesis of ROP.  
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5. Conclusion 
The increased survival of very small premature infants in modern NICUs led to increasing 
the incidence of ROP (Gibson et al, 1990; Gibson et al, 1990). Since ROP may produce serious 
sequel of infant blindness, all efforts must be made to prevent the development of advanced 
ROP. Identification of ROP risk factors will help to understand and predict ROP 
development in premature newborns (Akkoyun et al, 2006). One such risk factor may be 
multiple blood transfusions. Studies on the role of blood transfusion in ROP however have 
been hampered by the multifactorial nature of this disease and by the fact that most risk 
factors For ROP, including blood transfusions, are closely related to prematurity and are 
thus highly interdependent. This makes it different to define the specific role of any 
individual factor in the pathogenesis of ROP (Hesse et al 1997).      
Using multivariate regression analysis ,which provides a helpful tool in such a situation, 
some studies demonstrated that blood transfusion had a strong and dose-dependent influence 
on the development of ROP ( Hesse et al 1997; Cooke et al, 1993; Dani  et al , 2001 ).Otherwise, 
some investigators reported that the limitation of blood transfusion dose not affect ROP 
incidence(Bossi et al, 1984;Brooks et al 1999).  
The reported mechanisms by which blood transfusions could contribute to the development 
of ROP are (1) the increase of Oxygen delivery to the retina (James&Greenough&Naik, 1997) 
due to lower oxygen affinity of adult hemoglobin in pack red cell (Cooke et al, 1993), and (2) 
the secondary iron overload. 
The reduced iron-binding capacity of preterm infants due to their low transferring levels 
(Scott et al, 1975) makes preterm infants who are repeatedly transfused extremely 
susceptible to an accumulation of increased amounts of free iron. This problem catalyze 
Fenton reactions which produce free hydroxyl radicals capable of damaging the retina 
(Wardle et al, 2002).Despite a strong and independent association between ROP and blood 
transfusions, parameter suggestive of increased free iron, such as low transfusion or high 
ferritin levels, there not found to be independently associated with ROP in the one of related 
studies (Hesse et al 1997). It cannot be concluded from this data that a more restrictive 
transfusion policy will reduce the incidence of ROP, particularly as there is evidence that 
low levels of tissue oxygenation, which would be expected if VLBW infants are transfused 
less frequently, may also be a risk for ROP (Bauer & Windmayer, 1981). Otherwise, 
transfusion practices may differ considerably among both institutions and individual 
physicians because of a lack of uniformly accepted physiologic or evidence–based 
transfusion criteria (Brown &Berman&Luckey, 1990). 
Decisions about transfusing VLBW infants with RBCs should be based on the risks and 
benefits of applying various transfusions guidelines and further refining based on the 
clinical status of individual infants .Recent studies suggests that frequent transfusions did 
not offer a detectable advantage and restricted transfusion did not have an increased risk for 
major brain injury as reported in previous studies (Ross et al, 1989; Chen et al, 2009) 
Albeit, these results must be interpreted with caution, because they may be related to other 
co practices in the specific NICU. 
Further studies will be required to clarify whether as reduction in the number of 
transfusions will ultimately result in a reduced incidence of ROP without any significant 
difference in clinical outcome 
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